Contact this trialFirst, we need to learn more about you.
BTK Inhibitor
LOXO-305 for Mantle Cell Lymphoma
Recruiting2 awardsPhase 3
Winnipeg, Manitoba
This trial is testing a new cancer drug against other approved drugs to see if it is more effective. It is for people with mantle cell lymphoma, a type of blood cancer, and could last up to two years.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service